Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
Nanomolar inhibitor of the galectin-8 N-terminal domain binds via a non-canonical cation-π interaction
ID
Purić, Edvin
(
Author
),
ID
Hassan, Mujtaba
(
Author
),
ID
Sjövall, Fredrik
(
Author
),
ID
Tomašič, Tihomir
(
Author
),
ID
Pevec, Mojca
(
Author
),
ID
Lah, Jurij
(
Author
),
ID
Adrover Forteza, Jaume
(
Author
),
ID
Sundin, Anders
(
Author
),
ID
Leffler, Hakon
(
Author
),
ID
Nilsson, Ulf
(
Author
),
ID
Logan, Derek T.
(
Author
),
ID
Anderluh, Marko
(
Author
)
PDF - Presentation file,
Download
(2,03 MB)
MD5: EAB02C81AC085713926C5F84C22150C6
URL - Source URL, Visit
https://www.nature.com/articles/s42004-025-01458-6
Image galllery
Abstract
Galectin-8 is a tandem-repeat galectin consisting of two distinct carbohydrate recognition domains and is a potential drug target. We have developed a library of galectin-8N inhibitors that exhibit high nanomolar Kd values as determined by a competitive fluorescence polarization assay. A detailed thermodynamic analysis of the binding of d-galactosides to galectin-8N by isothermal titration calorimetry reveals important differences in enthalpic and/or entropic contributions to binding. Contrary to expectations, the binding of 2-O-propargyl-d-galactoside was found to strongly increase the binding enthalpy, whereas the binding of 2-O-carboxymethylene-d-galactoside was surprisingly less enthalpy-driven. The results of our work suggest that the ethynyl group can successfully replace the carboxylate group when targeting the water-exposed guanidine moiety of a critical arginine residue. This results in only a minor loss of affinity and an adjusted enthalpic contribution to the overall binding due to non-canonical cation-π interactions, as evidenced by the obtained crystal structure of 2-O-propargyl-d-galactoside in complex with the N-terminal domain of galectin-8. Such an interaction has neither been identified nor discussed to date in a small-molecule ligand-protein complex.
Language:
English
Keywords:
carbohydrates
,
lead optimization
,
structure-based drug design
,
X-ray crystallography
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2025
Number of pages:
11 str.
Numbering:
Vol. 8, article 59
PID:
20.500.12556/RUL-167856
UDC:
615.4:54
ISSN on article:
2399-3669
DOI:
10.1038/s42004-025-01458-6
COBISS.SI-ID:
229077763
Publication date in RUL:
17.03.2025
Views:
419
Downloads:
442
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Communications chemistry
Shortened title:
Commun. chem.
Publisher:
Macmillan Publishers, part of Springer Nature
ISSN:
2399-3669
COBISS.SI-ID:
529716505
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
ogljikovi hidrati
,
optimizacija potencialnih strank
,
oblikovanje zdravil na osnovi strukture
,
rentgenska kristalografija
,
farmacevtska kemija
Projects
Funder:
EC - European Commission
Funding programme:
H2020
Project number:
765581
Name:
Multidisciplinary European Joint Doctorate in the Design and Development of Glyco Drugs
Acronym:
PhD4GlycoDrug
Funder:
Other - Other funder or multiple funders
Funding programme:
EUTOPIA PhD Co-tutelle Programme grante
Funder:
Other - Other funder or multiple funders
Funding programme:
The Swedish Research Council
Project number:
2020-03317
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P1-0208
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
J1-50026
Name:
Vloga novega sekvenčnega motiva bogatega z alanini pri kondenzaciji RNA-vezavnih proteinov
Funder:
Other - Other funder or multiple funders
Funding programme:
COST - European Cooperation in Science and Technology
Project number:
CA18103
Name:
Innogly
Funder:
Other - Other funder or multiple funders
Funding programme:
COST - European Cooperation in Science and Technology
Project number:
CA18132
Name:
GLYCONanoPROBES
Funder:
Other - Other funder or multiple funders
Funding programme:
Ministry of Education, Science, and Sport (MIZŠ) of the Republic of Slovenia and the European Regional Development Fund
Project number:
OP20.05187 RI-SI-EATRIS
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back